Temaz and Metastases to spine - from FDA reports


Summary

Metastases to spine is found among people who take Temaz, especially for people who are female, 40-49 old , have been taking the drug for 6 - 12 months, also take medication Ramipril, and have Schizophrenia. This review analyzes which people have Metastases to spine with Temaz. It is created by eHealthMe based on reports of 23,188 people who have side effects when taking Temaz from FDA , and is updated regularly.

What to expect?

If you take Temaz and have Metastases to spine, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Temaz and have Metastases to spine

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Nov, 24, 2017

23,188 people reported to have side effects when taking Temaz.
Among them, 128 people (0.55%) have Metastases to spine


Number of reports submitted per year:

Could Temaz cause Metastases to spine?

Time on Temaz when people have Metastases to spine *:

  • < 1 month: 0.0 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 100 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Metastases to spine when taking Temaz *:

  • female: 97.32 %
  • male: 2.68 %

Age of people who have Metastases to spine when taking Temaz *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.93 %
  • 40-49: 92.52 %
  • 50-59: 1.87 %
  • 60+: 4.67 %

Top conditions involved for these people *:

  • Schizophrenia (88 people, 68.75%)
  • Convulsion (63 people, 49.22%)
  • High Blood Pressure (58 people, 45.31%)
  • Depression (58 people, 45.31%)
  • Breast Cancer Metastatic (21 people, 16.41%)

Top co-used drugs for these people *:

  • Ramipril (91 people, 71.09%)
  • Lamotrigine (89 people, 69.53%)
  • Amisulpride (88 people, 68.75%)
  • Clozaril (72 people, 56.25%)
  • Zometa (34 people, 26.56%)

Top other side effects for these people *:

  • Thrombocytopenia (93 people, 72.66%)
  • Breast Infection (88 people, 68.75%)
  • White Blood Cell Count Increased (84 people, 65.62%)
  • Mental Impairment (74 people, 57.81%)
  • Breast Cancer (71 people, 55.47%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Metastases to spine when taking Temaz?

Expand the study to include all drugs with the same ingredients

Metastases to spine and drugs with ingredients of temazepam.

Expand the study to include reports from both FDA and eHealthMe

Metastases to spine and Temaz from FDA and eHealthMe reports

Temaz

Temaz has active ingredients of temazepam. It is often used in insomnia. (latest outcomes from Temaz 24,420 users)

Metastases to spine

Metastases to spine (cancer spreads to spine) has been reported by people with metastases to bone, breast cancer, breast cancer metastatic, high blood pressure, pain (latest reports from 3,002 Metastases to spine patients).

Browse all side effects of Temaz

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Metastases to spine

Metastases to spine

Could your condition cause Metastases to spine

Metastases to spine

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Temaz and have Metastases to spine.

Questions to the study

More questions >